Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Dec;98(12):1930–1933.

Racial and ethnic disparities in cancers of the uterine corpus.

O W Stephanie Yap 1, Roland P Matthews 1
PMCID: PMC2569671  PMID: 17225836

Abstract

Survival after diagnosis of cancer of the uterine corpus is significantly worse in black women as compared with white women. The etiology of the racial and ethnic disparities that exist in endometrial cancer incidence and outcome is multifactorial and complex. Potential explanations include cancer biology, differences in access to care, sociodemographic characteristics, response to treatment and comorbid factors. In this article, a review was performed to assess the magnitude and reasons for the observed disparity in endometrial cancer mortality. Strategies and recommendations to reduce or eliminate differences in endometrial cancer outcome are explored. These include advocacy for more research to clarify the underlying causes of cancer disparities at all levels, including the molecular basis of disparate outcomes, improving access to quality healthcare services, establishing culturally competent models of healthcare delivery, and developing novel cost-effective screening and early prevention methods.

Full text

PDF
1930

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aziz H., Rotman M., Hussain F., Smith G., Chan E., Choi K., Sohn C., Halpern J., Schwartz D., Aral I. Poor survival of black patients in carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):293–301. doi: 10.1016/0360-3016(93)90240-v. [DOI] [PubMed] [Google Scholar]
  2. Bain R. P., Greenberg R. S., Chung K. C. Racial differences in survival of women with endometrial cancer. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):914–923. doi: 10.1016/s0002-9378(87)80089-3. [DOI] [PubMed] [Google Scholar]
  3. Barrett R. J., 2nd, Harlan L. C., Wesley M. N., Hill H. A., Chen V. W., Clayton L. A., Kotz H. L., Eley J. W., Robboy S. J., Edwards B. K. Endometrial cancer: stage at diagnosis and associated factors in black and white patients. Am J Obstet Gynecol. 1995 Aug;173(2):414–423. doi: 10.1016/0002-9378(95)90261-9. [DOI] [PubMed] [Google Scholar]
  4. Clifford S. L., Kaminetsky C. P., Cirisano F. D., Dodge R., Soper J. T., Clarke-Pearson D. L., Berchuck A. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol. 1997 Jun;176(6):S229–S232. doi: 10.1016/s0002-9378(97)70380-6. [DOI] [PubMed] [Google Scholar]
  5. Connell P. P., Rotmensch J., Waggoner S. E., Mundt A. J. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 1999 Nov;94(5 Pt 1):713–720. doi: 10.1016/s0029-7844(99)00381-6. [DOI] [PubMed] [Google Scholar]
  6. Hicks M. L., Kim W., Abrams J., Johnson C. C., Blount A. C., Parham G. P. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 1997 Feb;89(2):134–140. [PMC free article] [PubMed] [Google Scholar]
  7. Hicks M. L., Phillips J. L., Parham G., Andrews N., Jones W. B., Shingleton H. M., Menck H. R. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998 Dec 15;83(12):2629–2637. doi: 10.1002/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  8. Ito K., Watanabe K., Nasim S., Sasano H., Sato S., Yajima A., Silverberg S. G., Garrett C. T. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res. 1994 Sep 1;54(17):4667–4670. [PubMed] [Google Scholar]
  9. Kohler M. F., Carney P., Dodge R., Soper J. T., Clarke-Pearson D. L., Marks J. R., Berchuck A. p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol. 1996 Nov;175(5):1246–1252. doi: 10.1016/s0002-9378(96)70036-4. [DOI] [PubMed] [Google Scholar]
  10. Kost Edward R., Hall Kevin L., Hines Jeffrey F., Farley John H., Nycum Lawrence R., Rose G. Scott, Carlson Jay W., Fischer Joseph R., Jr, Kendall Brian S. Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer. Gynecol Oncol. 2003 May;89(2):218–226. doi: 10.1016/s0090-8258(03)00050-7. [DOI] [PubMed] [Google Scholar]
  11. Liu J. R., Conaway M., Rodriguez G. C., Soper J. T., Clarke-Pearson D. L., Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995 Oct;86(4 Pt 1):486–490. doi: 10.1016/0029-7844(95)00238-m. [DOI] [PubMed] [Google Scholar]
  12. Madison T., Schottenfeld D., Baker V. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage. Cancer. 1998 Oct 15;83(8):1546–1554. doi: 10.1002/(sici)1097-0142(19981015)83:8<1546::aid-cncr9>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  13. Matthews R. P., Hutchinson-Colas J., Maiman M., Fruchter R. G., Gates E. J., Gibbon D., Remy J. C., Sedlis A. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 1997 May;65(2):206–212. doi: 10.1006/gyno.1997.4617. [DOI] [PubMed] [Google Scholar]
  14. Maxwell G. L., Risinger J. I., Hayes K. A., Alvarez A. A., Dodge R. K., Barrett J. C., Berchuck A. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res. 2000 Aug;6(8):2999–3005. [PubMed] [Google Scholar]
  15. Maxwell G. Larry, Chandramouli G. V. R., Dainty Lou, Litzi Tracy J., Berchuck Andrew, Barrett J. Carl, Risinger John I. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res. 2005 Jun 1;11(11):4056–4066. doi: 10.1158/1078-0432.CCR-04-2001. [DOI] [PubMed] [Google Scholar]
  16. Morgan M. A., Behbakht K., Benjamin I., Berlin M., King S. A., Rubin S. C. Racial differences in survival from gynecologic cancer. Obstet Gynecol. 1996 Dec;88(6):914–918. doi: 10.1016/s0029-7844(96)00342-0. [DOI] [PubMed] [Google Scholar]
  17. Plaxe S. C., Saltzstein S. L. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol. 1997 Apr;65(1):8–12. doi: 10.1006/gyno.1996.4594. [DOI] [PubMed] [Google Scholar]
  18. Randall Thomas C., Armstrong Katrina. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003 Nov 15;21(22):4200–4206. doi: 10.1200/JCO.2003.01.218. [DOI] [PubMed] [Google Scholar]
  19. Risinger J. I., Berchuck A., Kohler M. F., Watson P., Lynch H. T., Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res. 1993 Nov 1;53(21):5100–5103. [PubMed] [Google Scholar]
  20. Risinger J. I., Hayes K., Maxwell G. L., Carney M. E., Dodge R. K., Barrett J. C., Berchuck A. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res. 1998 Dec;4(12):3005–3010. [PubMed] [Google Scholar]
  21. Santin Alessandro D., Bellone Stefania, Siegel Eric R., Palmieri Michela, Thomas Maria, Cannon Martin J., Kay Helen H., Roman Juan J., Burnett Alexander, Pecorelli Sergio. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am J Obstet Gynecol. 2005 Mar;192(3):813–818. doi: 10.1016/j.ajog.2004.10.605. [DOI] [PubMed] [Google Scholar]
  22. Sherman Mark E., Devesa Susan S. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003 Jul 1;98(1):176–186. doi: 10.1002/cncr.11484. [DOI] [PubMed] [Google Scholar]
  23. Tashiro H., Isacson C., Levine R., Kurman R. J., Cho K. R., Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997 Jan;150(1):177–185. [PMC free article] [PubMed] [Google Scholar]
  24. Trimble Edward L., Harlan Linda C., Clegg Limin X., Stevens Jennifer L. Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol Oncol. 2005 Mar;96(3):741–748. doi: 10.1016/j.ygyno.2004.11.041. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES